Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hepatitis B 3Carcinoma, Hepatocellular 3Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 21Cyclosporine 14fludarabine phosphate 13Whole-Body Irradiation 13Peripheral Blood Stem Cell Transplantation 13Filgrastim 10Rituximab 9Mycophenolic Acid 9Antilymphocyte Serum 9Radiotherapy 7Methotrexate 7Busulfan 7Melphalan 6Psychiatric Rehabilitation 5Etoposide 5Dexamethasone 5Cytarabine 5Aprepitant 5fludarabine 4Vincristine 4Ondansetron 4Methylprednisolone 4Granulocyte Colony-Stimulating Factor 4Doxorubicin 4Cord Blood Stem Cell Transplantation 4plerixafor 3Zidovudine 3Therapeutics 3Stem Cell Transplantation 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Non-Hodgkin × entecavir × Clear all
NCT00931229 2016-11-09

Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients

National Health Research Institutes, Taiwan

Phase NA Unknown
202 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡